全文获取类型
收费全文 | 5089篇 |
免费 | 544篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 108篇 |
儿科学 | 125篇 |
妇产科学 | 45篇 |
基础医学 | 702篇 |
口腔科学 | 70篇 |
临床医学 | 648篇 |
内科学 | 1208篇 |
皮肤病学 | 39篇 |
神经病学 | 518篇 |
特种医学 | 412篇 |
外科学 | 649篇 |
综合类 | 91篇 |
一般理论 | 3篇 |
预防医学 | 366篇 |
眼科学 | 54篇 |
药学 | 349篇 |
中国医学 | 2篇 |
肿瘤学 | 266篇 |
出版年
2021年 | 49篇 |
2019年 | 51篇 |
2018年 | 54篇 |
2017年 | 45篇 |
2016年 | 63篇 |
2015年 | 67篇 |
2014年 | 86篇 |
2013年 | 151篇 |
2012年 | 196篇 |
2011年 | 192篇 |
2010年 | 123篇 |
2009年 | 125篇 |
2008年 | 160篇 |
2007年 | 187篇 |
2006年 | 198篇 |
2005年 | 222篇 |
2004年 | 202篇 |
2003年 | 224篇 |
2002年 | 175篇 |
2001年 | 206篇 |
2000年 | 196篇 |
1999年 | 180篇 |
1998年 | 101篇 |
1997年 | 100篇 |
1996年 | 87篇 |
1995年 | 86篇 |
1994年 | 91篇 |
1993年 | 59篇 |
1992年 | 138篇 |
1991年 | 124篇 |
1990年 | 122篇 |
1989年 | 128篇 |
1988年 | 120篇 |
1987年 | 119篇 |
1986年 | 105篇 |
1985年 | 103篇 |
1984年 | 72篇 |
1983年 | 75篇 |
1982年 | 53篇 |
1981年 | 64篇 |
1980年 | 52篇 |
1979年 | 48篇 |
1978年 | 71篇 |
1977年 | 55篇 |
1976年 | 45篇 |
1975年 | 44篇 |
1974年 | 40篇 |
1973年 | 51篇 |
1972年 | 35篇 |
1967年 | 39篇 |
排序方式: 共有5655条查询结果,搜索用时 15 毫秒
91.
92.
Suppression of apoptosis in hematopoietic factor-dependent progenitor cell lines by expression of the FAC gene 总被引:2,自引:5,他引:2
Fanconi anemia (FA) is a genetically heterogeneous, inherited blood disorder characterized by bone marrow failure, congenital malformations, and a predisposition to leukemias. Because FA cells are hypersensitive to DNA cross-linking agents and have chromosomal instability, FA has been viewed as a disorder of DNA repair. However, the exact cellular defect in FA cells has not been identified. Sequence analysis of the gene defective in group C patients (FAC) has shown no significant homologies to other known genes. The FAC protein has been localized to the cytoplasm, indicating that FAC may either play an indirect role in DNA repair or is involved in a different cellular pathway. Recent evidence has indicated that FA cells may be predisposed to apoptosis, especially after treatment with DNA cross-linking agents. The demonstration that genes can suppress apoptosis has been accomplished by overexpression of such genes in growth factor-dependent cell lines that die by apoptosis after factor withdrawal. Using retroviral-mediated gene transfer, we present evidence that expression of FAC in the hematopoietic factor-dependent progenitor cell lines 32D and MO7e can suppress apoptosis induced by growth factor withdrawal. Flow cytometry and morphologic analysis of propidium iodide stained cells showed significantly lower levels of apoptosis in FAC-retroviral transduced cells after growth factor deprivation. Expression of FAC in both cell lines promoted increased viability rather than proliferation, which is consistent with other apoptosis-inhibiting genes such as Bcl- 2. These findings imply that FAC may act as a mediator of an apoptotic pathway initiated by growth factor withdrawal. Furthermore, the congenital malformations and hematologic abnormalities characterizing FA may be related to an increased predisposition of FA progenitor cells to undergo apoptosis, particularly in the absence of extracellular signals. 相似文献
93.
94.
Migraine Care Challenges and Strategies in US Uninsured and Underinsured Adults: A Narrative Review,Part 2 下载免费PDF全文
Larry Charleston MD MSc IV Jeffrey Royce MD Teshamae S. Monteith MD Susan W. Broner MD Hope L. O'Brien MD Salvador L. Manrriquez DDS Matthew S. Robbins MD On behalf of the Underserved Populations in Headache Medicine Special Interest Section of the American Headache Society 《Headache》2018,58(5):633-647
95.
96.
97.
Valerie Voon Laurel S Morris Michael A Irvine Christian Ruck Yulia Worbe Katherine Derbyshire Vladan Rankov Liana RN Schreiber Brian L Odlaug Neil A Harrison Jonathan Wood Trevor W Robbins Edward T Bullmore Jon E Grant 《Neuropsychopharmacology》2015,40(4):804-812
Pathological behaviors toward drugs and food rewards have underlying commonalities. Risk-taking has a fourfold pattern varying as a function of probability and valence leading to the nonlinearity of probability weighting with overweighting of small probabilities and underweighting of large probabilities. Here we assess these influences on risk-taking in patients with pathological behaviors toward drug and food rewards and examine structural neural correlates of nonlinearity of probability weighting in healthy volunteers. In the anticipation of rewards, subjects with binge eating disorder show greater risk-taking, similar to substance-use disorders. Methamphetamine-dependent subjects had greater nonlinearity of probability weighting along with impaired subjective discrimination of probability and reward magnitude. Ex-smokers also had lower risk-taking to rewards compared with non-smokers. In the anticipation of losses, obesity without binge eating had a similar pattern to other substance-use disorders. Obese subjects with binge eating also have impaired discrimination of subjective value similar to that of the methamphetamine-dependent subjects. Nonlinearity of probability weighting was associated with lower gray matter volume in dorsolateral and ventromedial prefrontal cortex and orbitofrontal cortex in healthy volunteers. Our findings support a distinct subtype of binge eating disorder in obesity with similarities in risk-taking in the reward domain to substance use disorders. The results dovetail with the current approach of defining mechanistically based dimensional approaches rather than categorical approaches to psychiatric disorders. The relationship to risk probability and valence may underlie the propensity toward pathological behaviors toward different types of rewards. 相似文献
98.
99.
Outcomes of patients with differentiated thyroid carcinoma following initial therapy. 总被引:6,自引:0,他引:6
Jacqueline Jonklaas Nicholas J Sarlis Danielle Litofsky Kenneth B Ain S Thomas Bigos James D Brierley David S Cooper Bryan R Haugen Paul W Ladenson James Magner Jacob Robbins Douglas S Ross Monica Skarulis Harry R Maxon Steven I Sherman 《Thyroid》2006,16(12):1229-1242
This analysis was performed to determine the effect of initial therapy on the outcomes of thyroid cancer patients. The study setting was a prospectively followed multi-institutional registry. Patients were stratified as low risk (stages I and II) or high risk (stages III and IV). Treatments employed included near-total thyroidectomy, administration of radioactive iodine, and thyroid hormone suppression therapy. Outcome measures were overall survival, disease-specific survival, and disease-free survival. Near-total thyroidectomy, radioactive iodine, and aggressive thyroid hormone suppression therapy were each independently associated with longer overall survival in high-risk patients. Near-total thyroidectomy followed by radioactive iodine therapy, and moderate thyroid hormone suppression therapy, both predicted improved overall survival in stage II patients. No treatment modality, including lack of radioactive iodine, was associated with altered survival in stage I patients. Based on our overall survival data, we confirm that near-total thyroidectomy is indicated in high-risk patients. We also conclude that radioactive iodine therapy is beneficial for stage II, III, and IV patients. Importantly, we show for the first time that superior outcomes are associated with aggressive thyroid hormone suppression therapy in high-risk patients, but are achieved with modest suppression in stage II patients. We were unable to show any impact, positive or negative, of specific therapies in stage I patients. 相似文献
100.